A Multi-Center Evaluation of the Pharmacokinetics and Safety of Intravenous Ibuprofen in Infants 1-6 Months of Age

Overview

Journal Paediatr Drugs

Specialties Pediatrics
Pharmacology

Date 2023 Jun 9

PMID 37294477

Authors

Chris D Glover

John W Berkenbosch

Mary B Taylor

Nihar V Patel

Byron Kaelin

Breanne H Y Gibson

John Zhong

Affiliations

Soon will be listed here.

Abstract

Background: Enteral ibuprofen was first approved as a prescription drug in 1974 for the US market. An intravenous (IV) ibuprofen formulation is approved for use in children older than 6 months of age, but there are limited studies specifically evaluating the pharmacokinetics and safety in children 1-6 months of age.

Aims: The primary purpose of this study was to evaluate the pharmacokinetics of IV ibuprofen in infants younger than 6 months of age. The secondary objective was to evaluate the safety of single and repeated doses of IV ibuprofen in infants younger than 6 months of age.

Methods: This was an industry-sponsored multi-center study. Institutional Review Board approval and informed parental consent were obtained prior to enrollment. Hospitalized neonates and infants younger than 6 months of age with fever or expected postoperative pain were eligible. Enrolled patients received 10 mg/kg of IV ibuprofen every 6 h, with up to four doses per day. Patients were randomized to two sparse sampling technique pharmacokinetic sample time groups. Group 1 samples were drawn at 0, 30 min, and 2 h, while group 2 samples were drawn at 0 min, 1, and 4 h after administration.

Results: A total of 24 children were enrolled in the study, with 15 male patients and 9 female patients. The median age of the cohort was 4.4 months (range 1.1-5.9 months), and the median weight was 5.9 kg (range 2.3-8.8 kg). The arithmetic mean and standard error for peak plasma ibuprofen concentration was 56.28 ± 2.77 µg/mL. Plasma levels declined rapidly with a mean elimination half-life of 1.30 h. Time to peak ibuprofen effect and concentration were similar when compared with older pediatric patients. Clearance and volume of distribution were also similar to those reported in older pediatric patients. No drug-related adverse events were reported.

Conclusions: The pharmacokinetic and short-term safety profiles of IV ibuprofen in pediatric patients 1-6 months of age are comparable to those in children older than 6 months of age.

Trial Registration: Clinicaltrials.gov Trial Registration number and date: NCT02583399-Registered July 2017.

Citing Articles

Intravenously Administered Nonsteroidal Anti-Inflammatory Drugs in Clinical Practice: A Narrative Review.

Maurice-Szamburski A, Quemeneur C, Rozier R, Cuvillon P, Ecoffey C Pharmacy (Basel). 2025; 13(1).

PMID: 39998016 PMC: 11859530. DOI: 10.3390/pharmacy13010018.

Real-world evaluation of select adverse drug reactions and healthcare utilization associated with parenteral Ibuprofen and ketorolac in adult and pediatric patients.

Afolabi M, Rodriguez-Silva J, Chopra I, Macias-Perez I, Makii J, Durr E Front Pain Res (Lausanne). 2025; 5():1484948.

PMID: 39839198 PMC: 11746909. DOI: 10.3389/fpain.2024.1484948.

Comparison of Intravenous Ibuprofen Versus Intravenous Ketorolac in Acute Postoperative Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Nair A, Bodhey A, Jabri A, Al Sawafi F, Dudhedia U Cureus. 2024; 16(11):e73759.

PMID: 39677212 PMC: 11646476. DOI: 10.7759/cureus.73759.

Updating Clinical Practice: Improving Perioperative Pain Management for Adeno-Tonsillectomy in Children.

Redondo-Enriquez J, Rivas-Medina M, Galan-Mateos M Children (Basel). 2024; 11(10).

PMID: 39457155 PMC: 11505956. DOI: 10.3390/children11101190.

References

Mencia S, Alonso C, Pallas-Alonso C, Lopez-Herce J, Maternal And Child Health And Development Network Ii Samid Ii . Evaluation and Treatment of Pain in Fetuses, Neonates and Children. Children (Basel). 2022; 9(11). PMC: 9689143. DOI: 10.3390/children9111688. View

Doria M, Careddu D, Iorio R, Verrotti A, Chiappini E, Barbero G . Paracetamol and Ibuprofen in the Treatment of Fever and Acute Mild-Moderate Pain in Children: Italian Experts' Consensus Statements. Children (Basel). 2021; 8(10). PMC: 8534871. DOI: 10.3390/children8100873. View

Pierce C, Voss B . Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review. Ann Pharmacother. 2010; 44(3):489-506. DOI: 10.1345/aph.1M332. View

Yu Y, Tan Y, Xie C, Hu Q, OuYang J, Chen Y . Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer. JAMA Netw Open. 2020; 3(12):e2028086. PMC: 7724560. DOI: 10.1001/jamanetworkopen.2020.28086. View

Pavliv L, Voss B, Rock A . Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults. Am J Health Syst Pharm. 2010; 68(1):47-51. DOI: 10.2146/ajhp100120. View

SCHWARTZ J, Chan C, Mukhopadhyay S, Mcbride K, Jones T, Adcock S . Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin Pharmacol Ther. 1999; 65(6):653-60. DOI: 10.1016/S0009-9236(99)90087-5. View

Smith H, Voss B . Pharmacokinetics of intravenous ibuprofen: implications of time of infusion in the treatment of pain and fever. Drugs. 2012; 72(3):327-37. DOI: 10.2165/11599230-000000000-00000. View

Southworth S, Peters J, Rock A, Pavliv L . A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Clin Ther. 2009; 31(9):1922-35. DOI: 10.1016/j.clinthera.2009.08.026. View

Bookstaver P, Miller A, Rudisill C, Norris L . Intravenous ibuprofen: the first injectable product for the treatment of pain and fever. J Pain Res. 2011; 3:67-79. PMC: 3004645. DOI: 10.2147/jpr.s6993. View

10.

Capparelli E . Pharmacologic, pharmacodynamic, and pharmacokinetic considerations with intravenous Ibuprofen lysine. J Pediatr Pharmacol Ther. 2012; 12(3):158-70. PMC: 3462098. DOI: 10.5863/1551-6776-12.3.158. View

11.

Southworth S, Sellers J . Narrative Summary of Recently Published Literature on Intravenous Ibuprofen. Clin Ther. 2020; 42(7):1210-1221. DOI: 10.1016/j.clinthera.2020.05.004. View

12.

Khalil S, Hahn B, Chumpitazi C, Rock A, Kaelin B, Macias C . A multicenter, randomized, open-label, active-comparator trial to determine the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for treatment of fever in hospitalized pediatric patients. BMC Pediatr. 2017; 17(1):42. PMC: 5286864. DOI: 10.1186/s12887-017-0795-y. View

13.

Lovecchio F, Premkumar A, Stepan J, Albert T . Fighting Back: Institutional Strategies to Combat the Opioid Epidemic: A Systematic Review. HSS J. 2019; 15(1):66-71. PMC: 6384220. DOI: 10.1007/s11420-018-09662-y. View

14.

Han T, Chen H, Chen J, Cui J, Shen W . Testing the circulation of expanded flaps-prevention of necrosis of expanded flaps (a clinic study). Front Pediatr. 2023; 10:976150. PMC: 9909221. DOI: 10.3389/fped.2022.976150. View

15.

Patel K, Partain M, Ryan D, Hersh C, Goldenberg P, Hartnick C . Carotid artery mobilization prior to pharyngeal flap inset for patients with 22q11.2 deletion syndrome. Int J Pediatr Otorhinolaryngol. 2020; 141:110573. DOI: 10.1016/j.ijporl.2020.110573. View

16.

Abdelbaser I, Abo-Zeid M, Hayes S, Taman H . The Analgesic Effects of the Addition of Intravenous Ibuprofen to a Multimodal Analgesia Regimen for Pain Management After Pediatric Cardiac Surgery: A Randomized Controlled Study. J Cardiothorac Vasc Anesth. 2022; 37(3):445-450. DOI: 10.1053/j.jvca.2022.11.016. View

17.

Gokmen T, Erdeve O, Altug N, Oguz S, Uras N, Dilmen U . Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr. 2010; 158(4):549-554.e1. DOI: 10.1016/j.jpeds.2010.10.008. View

18.

Aranda J, Thomas R . Systematic review: intravenous Ibuprofen in preterm newborns. Semin Perinatol. 2006; 30(3):114-20. DOI: 10.1053/j.semperi.2006.04.003. View

19.

Ohlsson A, Aher S . Early erythropoiesis-stimulating agents in preterm or low birth weight infants. Cochrane Database Syst Rev. 2020; 2:CD004863. PMC: 7014351. DOI: 10.1002/14651858.CD004863.pub6. View

20.

Kozlowski L, Kost-Byerly S, Colantuoni E, Thompson C, Vasquenza K, Rothman S . Pain prevalence, intensity, assessment and management in a hospitalized pediatric population. Pain Manag Nurs. 2014; 15(1):22-35. DOI: 10.1016/j.pmn.2012.04.003. View